|
GXYLT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.024400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.459800E-01 |
| Normal-vs-Stage2 |
9.153800E-01 |
| Normal-vs-Stage3 |
2.579200E-01 |
| Normal-vs-Stage4 |
1.884360E-01 |
| Stage1-vs-Stage2 |
9.461000E-01 |
| Stage1-vs-Stage3 |
1.153350E-01 |
| Stage1-vs-Stage4 |
1.019840E-01 |
| Stage2-vs-Stage3 |
2.655600E-01 |
| Stage2-vs-Stage4 |
2.276600E-01 |
| Stage3-vs-Stage4 |
7.407200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.393200E-01 |
| Normal-vs-AfricanAmerican |
1.893000E-01 |
| Normal-vs-Asian |
3.720000E-01 |
| Caucasian-vs-AfricanAmerican |
6.396100E-02 |
| Caucasian-vs-Asian |
5.560400E-01 |
| AfricanAmerican-vs-Asian |
4.527900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.156800E-01 |
| Normal-vs-Female |
9.982000E-01 |
| Male-vs-Female |
7.594200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.417400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.505200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.245200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.762300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.184400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.293700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.104130E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.768400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.443500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.307700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.369700E-04 |
| Classical-VS-Follicular |
2.036300E-02 |
| Classical-VS-Other |
3.635200E-01 |
| Classical-VS-Normal |
5.631400E-01 |
| Tall-VS-Follicular |
2.947400E-01 |
| Tall-VS-Other |
7.575400E-01 |
| Tall-VS-Normal |
3.655800E-02 |
| Follicular-VS-Other |
9.118600E-01 |
| Follicular-VS-Normal |
2.242400E-01 |
| Other-VS-Normal |
4.667400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.625600E-01 |
| Normal-vs-N1 |
1.227240E-01 |
| N0-vs-N1 |
2.828400E-01 |
|
|
